首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >6-Substituted 1H-quinolin-2-ones and 2-methoxy-quinolines: synthesis and evaluation as inhibitors of steroid 5alpha reductases types 1 and 2.
【24h】

6-Substituted 1H-quinolin-2-ones and 2-methoxy-quinolines: synthesis and evaluation as inhibitors of steroid 5alpha reductases types 1 and 2.

机译:6-取代的1H-喹啉-2-酮和2-甲氧基-喹啉:合成和评估类固醇5α还原酶1和2的抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A Negishi-type coupling reaction between 6-bromo-2-methoxyquinoline (1a) and various 4-bromo-N,N-dialkyl-benzamides gave access to 6-substituted 2-methoxy-quinolines 1-3 and 1H-quinolin-2-ones 4-12. Most of these compound proved to be inhibitors of steroid 5alpha reductases with activity and selectivity both being strongly dependent on the features of the heterocycle and the size of the N,N-dialkylamide substituent. The most active inhibitor for the human type 2 isozyme was 6-[4-(N,N-diisopropylcarbamoyl)phenyl]-1H-quinolin-2-one 4 (Ki 800 +/- 85 nM), showing mostly competitive inhibitory patterns. A type 1 selective inhibitor could be identified with 6-[4-(N,N-diisopropylcarbamoyl)phenyl]-N-methyl-quinolin-2-one (5, IC50 510 nM).
机译:6-溴-2-甲氧基喹啉(1a)与各种4-溴-N,N-二烷基苯甲酰胺之间的Negishi型偶联反应可得到6-取代的2-甲氧基-喹啉1-3和1H-喹啉-2 -4-12。这些化合物大多数被证明是类固醇5α还原酶的抑制剂,其活性和选择性都强烈取决于杂环的特征和N,N-二烷基酰胺取代基的大小。对人类2型同工酶而言,活性最高的抑制剂是6- [4-(N,N-二异丙基氨基甲酰基)苯基] -1H-喹啉-2-酮4(Ki 800 +/- 85 nM),显示出主要的竞争性抑制模式。 1型选择性抑制剂可通过6- [4-(N,N-二异丙基氨基甲酰基)苯基] -N-甲基喹啉-2-酮(5,IC50 510 nM)鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号